ELISA 분석기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 모드별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global ELISA Analyzers Market was valued at USD 610.85 Million in 2024 and is projected to reach USD 759.24 Million by 2030, growing at a CAGR of 3.65%. ELISA (Enzyme-Linked Immunosorbent Assay) analyzers are essential diagnostic instruments used for detecting and quantifying biomolecules, including antibodies, antigens, proteins, and hormones. These systems are increasingly used across a range of applications such as immunology, vaccine development, and drug monitoring. The growing global burden of chronic and infectious diseases is fueling demand for accurate, high-throughput diagnostic solutions, making ELISA analyzers a critical tool in modern healthcare diagnostics. As healthcare systems prioritize early detection, monitoring, and targeted treatments, ELISA technologies are seeing widespread adoption across diagnostic laboratories, pharmaceutical companies, and research organizations. Advances in automation and assay sensitivity continue to enhance the utility and scalability of ELISA analyzers, supporting their expanding role in precision medicine and clinical diagnostics.

Key Market Drivers

Growing Prevalence of Chronic and Infectious Diseases

The increasing incidence of chronic and infectious diseases is a primary force driving the global ELISA Analyzers Market. Noncommunicable diseases (NCDs) were responsible for approximately 43 million deaths in 2021, accounting for 75% of non-pandemic-related mortality. Notably, 18 million of these deaths occurred in individuals under age 70, with 82% concentrated in low- and middle-income countries (LMICs). Chronic conditions such as diabetes, cancer, cardiovascular disorders, and infectious diseases like HIV/AIDS, hepatitis, and emerging viruses-including COVID-19 and Zika-are placing unprecedented pressure on global health systems. ELISA analyzers, valued for their sensitivity, reliability, and high-throughput capabilities, are being increasingly deployed for disease diagnosis, monitoring, and research. Their ability to support early detection and manage complex disease profiles is especially critical in aging populations and resource-constrained regions, where effective diagnostic infrastructure is essential for reducing morbidity and mortality.

Key Market Challenges

High Costs of ELISA Analyzers and Consumables

A major constraint in the ELISA Analyzers Market is the high cost associated with acquiring and operating these systems. Advanced ELISA analyzers, particularly automated variants, can require investments ranging from tens of thousands to hundreds of thousands of dollars, making them inaccessible for many small to medium-sized laboratories, particularly in LMICs. The financial burden extends beyond equipment procurement to recurring costs for consumables such as reagents, kits, and regular maintenance. This ongoing expense poses a significant barrier to adoption, especially in facilities with limited budgets or operating in price-sensitive markets. These cost pressures often delay upgrades to newer systems or prevent adoption altogether, thereby limiting diagnostic capabilities and widening healthcare disparities between developed and developing regions.

Key Market Trends

Rising Demand for Personalized and Precision Medicine

The evolution of healthcare toward personalized and precision medicine is significantly influencing the ELISA Analyzers Market. Precision medicine focuses on tailoring treatment based on individual patient profiles, including genetic, molecular, and environmental factors. ELISA analyzers are playing a pivotal role in this shift due to their ability to detect and quantify disease-specific biomarkers, enabling clinicians to diagnose conditions more accurately and select targeted therapies. These systems are increasingly used in oncology, autoimmune disease management, and genetic testing to guide clinical decision-making. By integrating ELISA technology with genomic and proteomic data, healthcare providers can better predict disease risk and optimize treatment plans. The growing emphasis on early diagnosis, targeted therapies, and treatment monitoring is expected to further accelerate the demand for high-performance ELISA analyzers and advanced assay development.

Key Market Players

• Thermo Fisher Scientific Inc.
• Abcam Limited
• Bio-Rad Laboratories, Inc.
• Merck KgaA
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Trinity Biotech Plc.
• Agilent Technologies, Inc.
• QIAGEN
• PerkinElmer U.S. LLC

Report Scope:

In this report, the Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Analyzers Market, By Product:

• Optical Filter ELISA Analyzer
• Optical Grating ELISA Analyzers

ELISA Analyzers Market, By Mode:

• Automated ELISA Analyzers
• Semi-Automated Analyzers

ELISA Analyzers Market, By Application:

• Immunology
• Vaccine Development
• Drug Monitoring
• Others

ELISA Analyzers Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organization
• Diagnostic Laboratories

ELISA Analyzers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global ELISA Analyzers Market.

Available Customizations:

Global ELISA Analyzers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. ELISA Analyzers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Optical Filter ELISA Analyzer, Optical Grating ELISA Analyzers)
  • 5.2.2. By Mode (Automated ELISA Analyzers, Semi-Automated Analyzers)
  • 5.2.3. By Application (Immunology, Vaccine development, Drug Monitoring, Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization, Diagnostic Laboratories)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America ELISA Analyzers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Mode
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States ELISA Analyzers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Mode
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada ELISA Analyzers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Mode
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico ELISA Analyzers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Mode
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe ELISA Analyzers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Mode
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany ELISA Analyzers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Mode
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom ELISA Analyzers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Mode
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy ELISA Analyzers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Mode
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France ELISA Analyzers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Mode
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain ELISA Analyzers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Mode
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific ELISA Analyzers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Mode
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China ELISA Analyzers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Mode
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India ELISA Analyzers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Mode
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan ELISA Analyzers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Mode
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea ELISA Analyzers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Mode
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia ELISA Analyzers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Mode
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America ELISA Analyzers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Mode
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil ELISA Analyzers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Mode
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina ELISA Analyzers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Mode
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia ELISA Analyzers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Mode
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa ELISA Analyzers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Mode
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa ELISA Analyzers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Mode
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia ELISA Analyzers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Mode
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE ELISA Analyzers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Mode
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global ELISA Analyzers Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Abcam Limited
• 14.3. Bio-Rad Laboratories, Inc.
• 14.4. Merck KgaA
• 14.5. F. Hoffmann-La Roche Ltd
• 14.6. Danaher Corporation
• 14.7. Trinity Biotech Plc.
• 14.8. Agilent Technologies, Inc.
• 14.9. QIAGEN
• 14.10.PerkinElmer U.S. LLC.

15. Strategic Recommendations

16. About Us & Disclaimer